Markus Friedrich Neurath - Nanotechnology

Author Information

Markus Friedrich Neurath is affiliated with the Department of Medicine 1, Kussmaul Campus for Medical Research and Translational Research Center, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany. His extensive research focuses on immunology, particularly in the context of cancer and inflammatory diseases.

Research Contributions

Markus Friedrich Neurath has made significant contributions to the fields of immunology and gastroenterology. In 2022 alone, he published multiple papers on topics including the role of IL-9 producing lymphocytes in non-small cell lung cancer, non-invasive assessment techniques for inflammatory activities in ulcerative colitis, and the impact of epithelial cell shedding on intestinal homeostasis. His research also delved into the potential of nanoparticles as a future therapy for inflammatory bowel disease (IBD) and the inhibition of SMYD2 in reducing SARS-CoV-2 infection in epithelial cells. His work is highly influential in developing novel diagnostic and therapeutic strategies in these areas.

Aliases

Markus Friedrich Neurath is also known by various aliases, including Markus F Neurath, M F Neurath, Markus F. Neurath, M. F. Neurath, and several other variations. These aliases are often used interchangeably in academic publications and citations.

Publication and Citation Metrics

Metric	Value
Total Citation Count	72,527
h-index	131
Total Paper Count	1,301

Publications:

IL-9 Producing Tumor-Infiltrating Lymphocytes and Treg Subsets Drive Immune Escape of Tumor Cells in Non-Small Cell Lung Cancer

DOI: 10.3389/fimmu.2022.859738

Year: 2022

DOP12 Non-invasive assessment of intestinal inflammatory activity in Ulcerative Colitis by Multispectral Optoacoustic Tomography (MSOT)

DOI: 10.1093/ecco-jcc/jjab232.051

Year: 2022

Natural NADH and FAD Autofluorescence as Label-Free Biomarkers for Discriminating Subtypes and Functional States of Immune Cells

DOI: 10.3390/ijms23042338

Year: 2022

Impact of Epithelial Cell Shedding on Intestinal Homeostasis

DOI: 10.3390/ijms23084160

Year: 2022

SMYD2 Inhibition Downregulates TMPRSS2 and Decreases SARS-CoV-2 Infection in Human Intestinal and Airway Epithelial Cells

DOI: 10.3390/cells11081262

Year: 2022

Telomerase deficiency reflects age-associated changes in CD4+ T cells

DOI: 10.1186/s12979-022-00273-0

Year: 2022

Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis

DOI: 10.1136/gutjnl-2022-327075

Year: 2022

Motorized Spiral Enteroscopy: Results of an international, multicenter, prospective observational clinical study on patients with normal and altered gastrointestinal anatomy.

DOI: 10.1055/a-1831-6215

Year: 2022

Small but powerful: will nanoparticles be the future state‐of‐the‐art therapy for IBD?

DOI: 10.1080/17425247.2022.2043847

Year: 2022

Targeting STAT3 Signaling in COL1+ Fibroblasts Controls Colitis-Associated Cancer in Mice

DOI: 10.3390/cancers14061472

Year: 2022

What is the Future of Nanotechnology in Metastatic Cancer Treatment?

Why Choose Weekly Full Backups in Nanotechnology?

What are the Applications of Biocompatible Stains in Nanotechnology?

How Are Binding Affinities Measured?

What are International Patents?

How Does Displacement Damage Occur?

Why is PCA Important in Nanotechnology?

What are the Potential Environmental Risks of Nanotechnology?

How to Initiate Collaboration?

What are the Economic Considerations in Resource Management?

Partnered Content Networks

Relevant Topics